It is well established that inflammation and apoptosis of renal tubular epithelial cells caused by hyperglycemia contribute to the development of diabetic nephropathy (DN). Although microRNAs (miRNAs) are known to have roles in inflammation-related disorders, the exact role of miR-34b in DN has not been defined, and the regulatory mechanism has been unclear. This study aimed to clarify the role of miR-34b in DN pathogenesis.
Background
Diabetic nephropathy is a leading cause of many high-mortality diseases such as end-stage renal disease (ESRD) and results in nephrotic syndrome [1] . The impaired renal function caused by diabetes can also accelerate microvascular complications such as cardiovascular disease and stroke [1, 2] . Although several methods are widely used for treating DN, most of these patients continue and to progress to renal injury [3, 4] . Thus, it is important to establish a novel therapeutic method to block DN progression in these patients.
Growing evidence indicate that tubular cells are a primary target of DN, which has an important role in the pathogenesis and progression of this disease [5] . Tubular atrophy results in DN-induced tubular injury, in which there is increased apoptosis in the distal and proximal tubular epithelial cells. Recently, several studies reported that imflamation and apoptosis of renal tubular epithelial cells can be found in both DM patients and DM animal models [6, 7] . A preclinical study by Shi et al. showed that high glucose (HG)-induced tubular cell damage suppresses the ability of these cells to maintain homeostasis and ultimately leads to renal insufficiency [8] . Despite these studies of renal tubular cell apoptosis [9] , details of the mechanism by which HG induces apoptosis in renal tubular epithelial cells has been unclear.
MicroRNAs (miRNAs) are small non-coding RNAs that perform post-transcriptional mediation of gene expression [10] [11] [12] [13] and are involved in various cellular processes such as angiogenesis [14] , differentiation [15] , proliferation [16] , and apoptosis [17] . Furthermore, recent studies have demonstrated that miRNAs targeted against genes involved in renal tubular epithelial cells might be potential candidates for use in anti-apoptotic therapies for DN. For example, Zhu et al. suggested that miR-181a can induce tubular epithelial cell apoptosis by suppressing expression of the Bcl-2 family, and showed that this process was inhibited by cisplatin [18] . A study by Huang et al. reported that miR-125b mediates HG-induced apoptosis and ROS production in HK-2 cells by targeting ACE2 [19] . At present, miRNAs are thought to be involved in regulating the DN process, and investigations on the influence miRNA and their target have shown promising results. Recent studies found that miR-34b levels are greatly increased in inflammation-related diseases such as acute graft-versus-host disease and intracranial aneurysms [20, 21] , suggesting miR-34b is involved with inflammation-related signaling pathways. However, the mechanism of miR-34b in DN is still unclear.
Therefore, the purpose of this study was to elucidate the possible mechanism by which miR-34b is involved in HG-induced HK-2 cells. In the present study, we assessed miR-34b expression and the effects of miR-34b on accumulation of inflammatory cytokines and apoptosis in HG-treated HK-2 cells, focusing on the target of miR-34b and its downstream JAK2/STAT3 pathway, which mainly involved in inflammation and apoptosis.
Material and Methods

Cell culture
The HK-2 cells, which are considered as to be a proximal tubular cell line [22] , were obtained from ScienCell™ Corporation (Carlsbad, CA, USA) and were cultured in DMEM-F12 culture medium (GIBCO, Invitrogen, Grand Island, NY, USA). The culture medium were supplemented with 10% fetal bovine serum (FBS) and mixed with 100 U/ml penicillin and 100 mg/ml streptomycin and incubated in 5% CO 2 and 37°C. To assess the effects of HG, HK-2 cells were added and recultured at a density of 5×10 5 cells in a 12-well plate. After that, cells were cultured in serum-free cell culture medium containing 20 mM glucose (HG) or 5 mM glucose (normal glucose, NG) for 12 h, 24 h, 48 h, and 72 h. The treated cells were incubated and collected for the following experiments. The HEK293 cells were cultured according to the manufacturer's specifications and as detailed in a previous study [23] .
ELISA assays
To detemine the inflammatory factors produced by cells, ELISA was performed according to the manufacturer's protocols. Different groups of HK-2 cells (4×10 5 /per well) were seeded in a 12-well plate and cultured for 24 h. Then, the cells were collected and lysed, and a BCA protein assay kit was used to detect concentrations of proteins. After that, the specific IL-6 ELISA kit was used to determine the amounts of inflammatory factors present in the supernatants. Enzyme activity was measured by detecting fluorescence using a spectrofluorophotometer. All assays were performed in duplicate and repeated 3 times.
Cell transfections
Before transfection, the HK-2 cells were incubated in a 6-well plate overnight. Next, all cells were transfected with miR-34b mimic, miR-34b inhibitor, and negative controls using Lipofectamine 2000 reagent (Invitrogen; Thermo Fisher Scientific). The IL-6R sequence (Gene-bank: NM_000565.3) was synthesized according to the full-length IL-6R sequence (based on the IR-6R sequence) and then cloned into a pcDNA3.1 vector (Invitrogen; Thermo Fisher Scientific) and empty vector was defined and considered as a control. After 48 h of transfection, the cells were used for further experiments.
qRT-PCR
To detect gene expression, quantitative real-time polymerase chain reaction (qRT-PCR) was performed. A total RNA isolation kit was used to isolate total RNA according to the manufacturer's instructions. Briefly, total RNA was extracted from podocytes using TRIZOl reagent (Sigma, CA, USA). Then, 1 μg RNA per sample was used to generated cDNA using the Verso cDNA synthesis kit (Thermo Scientific). The RT-qPCR mixture system comprised cDNA templates, primers, and and SYBR Green qPCR Master Mix (Thermo Scientific). Conditions were 95°C for 30 s and 40 cycles of amplification. The results are expressed as fold change using the DDCt method compared with control. GAPDH or U6 was used as an internal control to normalize gene expression for mRNA and miRNA, respectively. The primer information is shown in Table 1 .
Western blots
Western blot analysis was used for protein detection, and the process was conducted as previously described [24] . Total proteins were extracted from HK-2 cells. As described previously, BCA protein assay was used to measure protein concentrations. Then, proteins were transferred to polyvinylidene difluoride (PVDF) membranes and the membranes were blocked by 5% nonfat milk for 2 h at 37°C. After rinsing, the membranes were incubated at 4°C overnight with primary antibodies. The primary polyclonal antibodies were: caspase-3; TNF-a, (1: 200, rabbit; Abcam); phosphorylated-STAT3 (p-STAT3), phosphorylated-JAK2 (p-JAK2), total STAT3 (t-STAT3), total JAK2 (t-JAK2) (1: 500, rabbit; Abcam); and IL-1b and IL-6 (1: 3000, rabbit; CA, USA). After adding secondary antibody, the binding was detected by Western Lightning Plus ECL reagent (Waltham, MA, USA). Densitometric analysis was quantified with Image-J software.
Luciferase assays
TargetScanHuman version 7.1 (http://www.targetscan.org) was used to predict the target sequences of miR-34b in IL-6R. We constructed the wild-type (WT) luciferase reporter vectors and the IL-6R 3'-untranslated region (3'-UTR), which included the miR-34b seed-binding sites. A pGL3 expression system (Promega, USA) was used to construct the recombinant IL-6R sequence (Gene-bank: NM_000565.3), which was synthesized according to the full-length IL-6R sequence. To build the pGL3-wt-IL-6R'-UTR and pGL3-mut-IL-6R-3'-UTR plasmids, the wild-type or mutant binding sites of IL-6R were trasfacted into the pGL3 vector. For the luciferase reporter assay, HEK-293T cells (1×10 4 ) were plated onto a 96-well plate and co-transfected with reporter constructs (0.2 µg), miR-34b mimic, or control miRNA (50 nM), and pRL-TK vector (0.03 µg, Promega). Luciferase activities were measured 48 h after transfection using the Dual-Luciferase Reporter Assay System (Promega). manufacturer's instructions. The tranfected cells (1×10 5 /well) were collected by trypsinization and resuspended in binding buffer, and then stained by FITC-Annexin V and propidium iodide (PI) in the dark for 15 min. Finally, the stained cells were detected using flow cytometry (BD Biosciences, USA).
Flow cytometric cell apoptosis assays
Data analysis
All data analyses were performed using SPSS 21.0 software (SPSS, Inc., Chicago, IL, USA), and all data are presented as mean ±SD. The figures were made by using GraphPad Prism 7.0. For two-group analysis, we used Student's t test, and for multiple groups analysis, we used one-way ANOVA. P-value £0.05 was considered as statistically significant.
Results
The expression of miR-34b is downregulated in HG-treated HK-2 cells
In the first experiment we used the DN cell model induced by HG in HK-2 cells. To assess the role of miR-34b in HG-treated HK-2 cells, we first established the HG damaged model as previously described [19] . The expression of miR-34b was detected and analyzed at different time points (25 mM for 12, 24, 48, and 72 h) by using RT-PCR. As shown in Figure 1 , the miR-34b expression was significantly downregulated in HG-treated HK-2 cells in a time-dependent manner, suggesting a role in pathological progression of DN.
miR-34b attenuated inflammation in HG-treated HK-2 cells
To assess the role of miR-34b in inflammatory response in DN, we detected the inflammatory factor in HG-treated HK-2 cells transfected with miR-34b mimic. The transfection efficiency of miR-34b mimic and miR-34b inhibitor in HK-2 cells was verified by qRT-PCR (Figure 2A) . Then, the inflammatiory factors such as TNF-a, IL-1b, and IL-6, which play major roles in DN progression, were measured in each group by RT-PCR and Western bolt. As shown in Figure 2B , mRNA expressions of the TNF-a, IL-1b, and IL-6 were significanlty decreased in the miR-34b overexpression group compared to the control groups. We also found that the protein levels of TNF-a, IL-1b, and IL-6 were remarkably decreased in the miR-34b mimic group ( Figure 2C-2E ). Taken together, these findings indicate that miR-34b attenuates inflammation in HG-treated HK-2 cells.
miR-34b attenuates apoptosis in HG-treated HK-2 cells
Because inflammation can lead to hyperglycemia-induced apoptosis, we next tested whether miR-34b is involved in apoptosis in HG-treated HK-2 cells. The results showed that, compared to the NG group, the apoptotic cells were significantly increased in HG-induced HK-2 cells. Meanwhile, the number of apoptotic cells was dramatically decreased in the miR-34b mimic group compared with controls ( Figure 3A, 3B ). As shown in Figure 3C , the caspase-3 mRNA expression was significantly higher in the HG group compared to the NG group, and was remarkably reduced in the miR-34b mimic group, showing that miR-34b can suppress apoptosis in HG-treated HK-2 cells. In addition, our results show that the protien level of cleaved caspase-3 was dramatically upregulated in the HG group compared to the NG group, and was attenuated by transfection of miR-34b mimic ( Figure 3D, 3E ). Taken together, our results demonstrate that miR-34b can attenuate apoptosis in HG-treated HK-2 cells.
IL-6R is confirmed to be a direct target of miR-34b
To further explore the molecular mechanisms of miR-34b in the HG-induced cell model, we assessed the potential target IL-6R by using bioinformatics algorithms ( Figure 4A ). To determine whether IL-6R is a direct target of miR-34b, the dual-luciferase reporter assay was used. We co-transfected wild-type pGL3-IL-6R-WT-3'-UTR or pGL3-IL-6R-Mut-3'-UTR with miR-34b mimic or miR-34b inhibitor in HEK-293T cells. As shown in Figure 4B , miR-34b overexpression clearly reduced the luciferase activity, and miR-34b knockdown showed the opposite effect, in which the relative activity of luciferase was not significantly different from the IL-6R-3'-UTR-Mut groups. To identify whether miR-34b regulated the expression of IL-6R in DN, we further measured the mRNA and protein level of IL-6R in HG-treated HK-2 cells. The results identified that overexpression of miR-34b suppressed the mRNA and protein levels of IL-6R, which was promoted by miR-34b knockdown ( Figure 4C-4E) . These data sugget that IL-6R is a direct target of miR-34b in HG-treated HK-2 cells. 
miR-34b attenuates inflammation and apoptosis by targeting IL-6R in HG-treated HK-2 cells
Previously, we comfirmed that IL-6R was a direct target of miR-34b, so we wanted to further investigate whether miR-34b mediates apoptosis and inflammatory response by IL-6R. Therefore, we investigated the factors related to inflammation and apoptotosis in HG-treated HK-2 cells transfected with pcDNA-IL-6R, empty vector, miR-34b mimic, or mimic-NC. Our results indicated that mRNA expression of caspase-3 and inflammatory factors as IL-1b, IL-6, and TNF-a was lower in HG-treated HK-2 cells transfected with miR-34b mimics, which could be rescued by co-transfection of pcDNA-IL-6R ( Figure 5A ). As illustrated in Figure 5B , 5C, the IL-6R overexpression also evidently abrogated the effects of miR-34b mimics on the protein expression of TNF-a, IL-1b, and IL-6 and activity of caspase-3 in HG-treated HK-2 cells. These results indicate that miR-34b protects HG-treated HK-2 cells from inflammation and apoptosis by targeting IL-6R.
miR-34b suppresses the activation of the JAK2/STAT3 signaling pathway
In order to explore the deep mechanism of miR-34b in regulating inflammation and apoptosis in HG-treated HK-2 cells, we detected the activation of JAK2/STAT3 pathway, as previous reported. As shown in Figure 6A , 6B, after transfection of miR-34b mimic into HG-induced HK-2 cells, the levels of p-STAT3 and p-JAK2 were significantly reduced compared with controls. Moreover, overexpression IL-6R distinctly suppressed effects of miR-34b mimic on the protein expression of p-STAT3 and p-JAK2 in HG-treated HK-2 cells (Figure 6C, 6D) . These data suggest that miR-34b can regulate the JAK2/STAT3 signaling pathway by targeting IL-6R in HG-treated HK-2 cells.
Discussion
The correlation between renal tubular epithelial cell death and the generation and progression of DN is explicit. Damage of renal tubular epithelial cells is one of the important pathogeneses associated with the development of DN and ESRD, and increasingly more researchers have suggested that renal tubular epithelial cells death participates in DN [25] . Risk factors leading to renal tubular epithelial cells death in DN are diverse, including nitrous oxide, inflammatory cytokine, fas ligand, and osmotic change [26] . Recently, increasing evidence suggests that inflammatory factors have key roles in damage to tubular epithelial cells [25] . For example, Ma et al. reported that IL-17a takes part in HG-induced renal injury by controlling expression of pro-inflammatory cytokines such as TNF-a, IL-6, CCL2, and CCL10 [27] . Therefore, the use of effective new therapeutic agents that specifically suppress inflammatory injury in DN may be useful strategies for protecting renal function.
miRNAs are a group of 21-23 nucleotide small non-coding RNAs, which have an effect on modulating targeted mRNA expression [10] [11] [12] [13] . Notably, there is already sufficient evidence to show that several miRNAs are key factors in regulating the pathological process of DN -some of them, such as miR-15b [28] , miR-214 [29] , and miR-29a [30] play protective roles, whereas others, such as miR-22 [31] and miR-31 [32] , serve as injury elements. The miR-34 family includes 3 miRNAs: miRNA-34a, which is encoded by its own transcript, and miRNA-34b and miRNA-34c [33] . miR-34 family members are found at high levels in colorectal cancer [34] [35] [36] , gastric cancer [37] , ovarian cancer [38] , pediatric leukemia [39] , and kidney cell cancer [40, 41] . These members are mainly induced by the tumor supressor p53 [42] and are involved in apoptosis [43] , indicating that miR-34b has important roles in cell apoptotis [46] . Although there is no direct proof that miR-34b regulates HK-2 cell death and inflammatory injury, we hypothesized that miR-34b suppression alleviates functional abnormalities via ameliorating the apoptosis and inflammation response in DN, as suggested by Liu et al. [47] . To determine the role of miR-34b in DN, we initially examined the in vitro expression of miR-34b in different groups, including an HG (25 mM glucose) group and an NG (5 mM glucose) group. We found that the expression of miR-34b was much lower in HG-treated HK-2 cells. Then, we assessed the influence of excessive expression of miR-34b on apoptosis, inflammation, and related functional experiments of HG-treated HK-2 cells. We found that miR-34b weakened the activation and release of caspase-3 and inflammatory cytokines such as TNF-a, IL-1b, and IL-6 in the DN cell model. Furthermore, we found that miR-34b can prevent inflammation and apoptosis in HG-treated HK-2 cells by targeting IL-6R. Our findings appear to contradict previous studies reporting miR-34b promotes apoptotis and inflammation [42, 44] . Likewise, Catuogno et al. reported that miR-34c-5p clearly increased resistance to paclitaxel-induced apoptosis by inhibiting p53 in lung cancer [48] . Similar to our results, another study found that miR-34c suppresses HG-induced apoptosis in podocytes via the Notch signaling pathway [47] . These conflicting results are mainly caused by different conditions of stimulation and cell types, indicating miR-34b might have various biological functions in different diseases. However, we believe it is necessary to further explore the mechanisms by which miR-34b induces apoptosis and inflammation in HG conditions.
Recent studies have suggested that the JAK2/STAT3 signaling pathway has a pivotal role in HG-induced injury by regulating inflammatory response, promoting insulin resistance, and modulating glucose intolerance [49, 50] . In light of the pathological progression in DN, Kan et al. reported that suppression of the JAK2/STAT3 signaling pathway attenuates glycation end-products-induced renal tubular hypertrophy [49] . Sun et al. also showed that inhibition of the JAK2/STAT3 signaling pathway ameliorates diabetic renal dysfunction and reduces the expression of inflammatory factor such as IL-6, TNF-a, and MCP-1 [50] . The current consensus is that IL-6 and IL-6R interaction modifies the dimerization of glycoprotein 130 (gp130) to activate the STAT3 signaling pathway [51] . Misso et al. previously demonstrated that miR-34a serves as regulator for phosphorylation of JAK2 and STAT3, and the IL-6R signal transducer feedback loop [52] . Rokavec et al. [53] found that the IL-6R/STAT3/miR-34a signaling pathway plays a key role in regulating p53 expression, which is widely believed to be involved in the apoptosis process. Therefore, we hypothesized that overexpression of miR-34b alleviates apoptosis and inflammation response in HG-induced HK-2 via the JAK2/STAT3 signaling pathway. Our results show that upregulation of miR-34b enhances phosphorylation of JAK2 and STAT3 in HG-treated HK-2 cells, which was rescued by IL-6R overexpression, demonstrating that miR-34b represses HG-induced inflammation and apoptosis via the IL-6R/JAK2/STAT3 pathway.
Conclusions
Our results suggest that the expression of miR-34b is significantly decreased in HG-induced HK-2 cells. Furthermore, miR-34b overexpression can attenuate HG-induced inflammation and apoptosis in HK-2 cells though the IL-6R/JAK2/STAT3 signaling pathway, indicating that miR-34b is a promising therapeutic traget of DN.
